α-synuclein (SNCA ) but not dynamin 3 (DNM3 ) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain

DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study

(2016) Joanne Trinh et al.   LANCET NEUROLOGY

Motor and nonmotor heterogeneity of LRRK2 -related and idiopathic Parkinson's disease

(2016) Connie Marras et al.   MOVEMENT DISORDERS

Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium

(2015) Karen Marder et al.   NEUROLOGY

The role ofSNCAandMAPTin Parkinson disease andLRRK2parkinsonism in the Tunisian Arab-Berber population

(2014) J. Trinh et al.   EUROPEAN JOURNAL OF NEUROLOGY

Disease Penetrance of Late-Onset Parkinsonism

(2014) Joanne Trinh et al.   JAMA Neurology

SNCA: Major genetic modifier of age at onset of Parkinson's disease

(2013) Kathrin Brockmann et al.   MOVEMENT DISORDERS

Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants

(2012) Teresa Botta-Orfila et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

A Search for SNCA 3′ UTR Variants Identified SNP rs356165 as a Determinant of Disease Risk and Onset Age in Parkinson’s Disease

(2011) Lucía F. Cardo et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease

(2011) Stefano Goldwurm et al.   MOVEMENT DISORDERS

High frequency and reduced penetrance of lRRK2 g2019S mutation among Parkinson's disease patients in Cantabria (Spain)

(2011) María Sierra et al.   MOVEMENT DISORDERS

SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein Level

(2010) Ignacio F. Mata et al.   ARCHIVES OF NEUROLOGY

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

(2009) Dennis W Dickson et al.   LANCET NEUROLOGY

No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort

(2009) Rubén Fernández-Santiago et al.   NEUROBIOLOGY OF AGING

The Gly2019Ser mutation in LRRK2is not fully penetrant in familial Parkinson's disease: the GenePD study

(2008) Jeanne C Latourelle et al.   BMC Medicine

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

(2008) Daniel G Healy et al.   LANCET NEUROLOGY

Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain

(2007) Julia Fuchs et al.   FASEB JOURNAL